期刊文献+

超高效液相串联质谱法检测人血浆中华法林及其代谢产物的浓度 被引量:1

Determination of Warfarin and Its Metabolite in Human Plasma by Ultra Performance Liquid Chromatography Tandem Quadrupole Mass Spectrometry(UPLC-MS/MS)
下载PDF
导出
摘要 目的:建立快速检测人血浆中华法林及其代谢产物7-羟基华法林浓度的UPLC-MS/MS方法。方法:用乙腈沉淀血浆蛋白的方法处理,运用Waters XEVO TQD三重四级杆液质联用仪,色谱柱为ACQUITY UPLCBEH C18柱(50 mm×2.1mm,1.7μm);流动相为乙腈-水(含0.1%甲酸),梯度洗脱,流速为0.4 ml·min-1,柱温为40℃,内标为华法林-d5;质谱条件:电喷雾离子化源(ESI),正离子检测模式。结果:华法林和代谢产物7-羟基华法林的保留时间分别为1.8 min和1.5 min,线性范围分别为25~2 000 ng·ml-1(r=0.999 3)和5~500 ng·ml-1(r=0.999 6),最低定量限分别为5,2.5 ng·ml-1,回收率分别为96.9%~105.3%,97.1%~103.3%,日内、日间RSD均〈10%。结论:该法准确可靠,操作简便,重复性好,适于检测人血浆中华法林及其代谢产物7-羟基华法林的浓度。 Objective:To establish an ultra performance liquid chromatography-tandem quadrupole mass spectrometry method for the determination of warfarin and its metabolite 7-hydroxywarfarin in human plasma. Methods: An ACQUITY UPLC? BEH C18 (50 mm × 2. 1 mm, 1. 7 μm) column was used as the stationary phase at 40℃. The mobile phase consisted of acetonitrile and water (con-taining 0. 1% formic acid) with gradient elution at a flow rate of 0. 4 ml·min-1 . Warfarin-d5 was used as the internal standard. The analytes were detected on a triple-quadrupole mass spectrometer equipped with an ESI interface in a positive mode. Results:The reten-tion time of warfarin and 7-hydroxywarfarin was 1. 8 min and 1. 5 min, respectively. Excellent linear calibration curve of warfarin and 7-hydroxywarfarin was obtained within the concentration range of 25-2 000 ng · ml-1 ( r =0. 999 3 ) and 5-500 ng · ml-1 ( r =0. 999 6), respectively. The lower limit of quantification of warfarin and 7-hydroxywarfarin was 5 ng·ml-1 and 2. 5 ng·ml-1 with the average recovery of 96. 9%-105. 3% and 97. 1% -103. 3%, respectively. The intra-and inter-day standard deviations were both less than 10%. Conclusion: The method is accurate and simple, and suitable for the determination of warfarin and its metabolite 7-hydroxywarfarin in human plasma.
出处 《中国药师》 CAS 2015年第3期364-367,共4页 China Pharmacist
基金 浙江省中西医结合学会临床药学科研基金(编号:2013LYSX014)
关键词 华法林 血药浓度 超高效液相串联质谱法 7-羟基华法林 Warfarin Plasma concentration UPLC-ESI-MS/MS 7-Hydroxywarfarin
  • 相关文献

参考文献7

二级参考文献121

  • 1胡永芳,周宏灏.CYP3A4,CYP3A5和MDR1基因多态性对环孢素处置的影响[J].中国药理学通报,2005,21(3):257-261. 被引量:34
  • 2王宪德,丁力,唐闽,马千里.华法林血浆浓度的测定在患者出院前后抗凝监测中的作用比较[J].河北医科大学学报,2006,27(5):344-346. 被引量:5
  • 3陈新谦,金有豫,汤光.新编药物学[M].第17版.北京:人民卫生出版社,2011:32-33.
  • 4Wadelius M,Chen LY,Eriksson N,et al.Association of warfarindose with genes involved in its action and metabolism[J].HumGenet,2007;121:23-34.
  • 5Wang L,McLeod HL,Weinshilboum RM.Genomics and drug re-sponse[J].N Engl J Med,2011;364:1144-1153.
  • 6Yang L,Ge W,Yu F,et al.Impact of VKORC1 gene polymorphismon interindividual and interethnic warfarin dosage requirement-asystematic review and meta analysis[J].Thrombosis Research,2010;125:e159-e166.
  • 7Schwarz Ul,Ritchie MD,Bradford Y,et al.Genetic determinants ofresponse to warfarin during initial anticoagulation[J].N Engl J Med,2008;358:999-1008.
  • 8Wadelius M,Chen LY,Lindh JD,et al.The largest prospectivewarfarin-treated cohort supports genetic forecasting[J].Blood,2009:113:784-792.
  • 9Sanderson S,Emery J,Higgins J.CYP2C9 gene variants,drug dose,and bleeding risk in warfarin-treated patients:a HuGEnet systematicreview and meta-analysis[J].Genet Med,2005;7:97-104.
  • 10Wadelius M,Chen LY,Eriksson N,et al.Association of warfarindose with genes involved in its action and metabolism[J].Hum Gen-et,2007;121:23-34.

共引文献143

同被引文献12

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部